Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Muscle Stimulation Devices Market – Insights
Muscle stimulation devices are used for elicitation of muscle contraction using electric impulses. These devices are used in physical therapy and weight loss. In the U.S., the Food and Drug Administration (FDA) regulates the use of muscle stimulation devices. Transcutaneous electrical nerve stimulation (TENS) and electrical muscle stimulation (EMS) deliver low voltage electric impulses to stimulate nerves. TENS is used to stimulate the sensory nerve endings and EMS for muscle contraction.
The global muscle stimulation devices market is estimated to account for US$ 912.1 Mn in terms of value by the end of 2027.
Global Muscle Stimulation Devices Market: Drivers
Increasing incidence of head and spinal cord injuries is expected to boost growth of the global muscle stimulation devices market over the forecast period. For instance, according to researchers at the National Spinal Cord Injury Statistical Center at University of Alabama at Birmingham, as of 2019, 17,730 new spinal cord injury cases occur annually and between 249,000 and 363,000 people are currently living with spinal cord injuries in the U.S.
Moreover, high number of athletes and fitness enthusiasts use electrical muscle stimulators to enhance their fitness and training regimens. These devices are also used in gyms and home care settings to augment exercise programs. Professional sportspersons use electrical muscle stimulators during warm-up sessions. Such scenario is also expected to aid in growth of the market.
North America region held dominant position in the global muscle stimulation devices market in 2019, accounting for 50.0% share in terms of value, followed by Europe.
Figure 1. Global Muscle Stimulation Devices Market Value (US$ Mn), by Region, 2019
Global Muscle Stimulation Devices Market: Restraints
Usage of devices such as electrical stimulators, galvanic stimulators, and TENS lacks standard guidelines and usage indications for various disorders. Moreover, there is lack of trained professionals and physiotherapists to guide patients in the usage of these devices. Therefore, lack of standard usage guidelines and trained manpower is expected to hinder growth of the global muscle stimulation devices market.
Lower awareness among general population regarding electrotherapy treatment modalities is also expected to restrain growth of the market.
TENS segment in the global muscle stimulation devices market was valued at US$ 449.7 Mn in 2019 and is expected to reach US$ 647.0 Mn by 2027 at a CAGR of 4.7% during the forecast period.
Market Trends/Key Takeaways
Electrical muscle stimulation (EMS) is widely used for warm-up sessions in gym. These devices are also used by sports professionals before endurance training. EMS devices are also used during cooling down sessions after vigorous activity as it works by stimulating muscles and producing soft contractions on the major group of the muscle.
Physiotherapists increasingly prefer galvanic stimulators or electrical muscle stimulators to regain the strength of atrophied muscles in stroke or spinal multiple sclerosis patients. These devices are also used for lower limb muscle rehabilitation, which assists in gait training for stroke patients.
Global Muscle Stimulation Devices Market: Competitive Landscape
Major players operating in the global muscle stimulation devices market include, DJO Global Inc., Zynex Inc., Neurometrix Inc., R.S. Medical Inc., and Omron Corporation.
Global Muscle Stimulation Devices Market: Key Developments
Major players in the market are adopting M&A strategies to enhance their market share. For instance, in February 2019, Colfax Corporation acquired DJO Global, Inc. for US$ 3.15 billion.
Players in the market are also focused on gaining patent for their novel technologies. For instance, in May 2019, NeuroMetrix, Inc. received the patent for ‘Measuring the ‘on-skin’ time of a TENS device in order to minimize skin irritation due to excessive uninterrupted wearing of the same’ from the U.S. Patent and Trademark Office.